9:05am ET
Health and Healthcare
Major Pharma Short Interest Slides
The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was lower.
BMY Coverage Page 26
12:45pm ET
Health and Healthcare
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further
Credit Suisse sees the Bristol-Myers Squibb gap with Merck getting even worse, even though it still has robust I-O franchise estimates for Bristol-Myers.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto, 21st Century Fox and More
The top analyst upgrades, downgrades and initiations seen on Monday morning include BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto and Twenty-First Century Fox.
10:35am ET
Health and Healthcare
Why Bristol-Myers Failure Is a Huge Win for Merck
Bristol-Myers Squibb shares took a nosedive early Friday's following an update in its late-stage Checkmate trial. But Bristol-Myer's failure was a big win for Merck.
9:45am ET
Health and Healthcare
Bristol-Myers Earnings Don’t Appear to Be Enough for Investors
Bristol-Myers Squibb released a better-than-expected second-quarter earnings report before the markets opened on Thursday.
8:25am ET
Health and Healthcare
Short Sellers Get Selective on Major Pharma
The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest was mixed.
8:35am ET
Health and Healthcare
Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016
SunTrust Robinson Humphrey feels that the major pharmaceutical companies will outperform the rest of the year, and they cite new products, attractive dividends and solid performance as positives.
9:15am ET
Health and Healthcare
Short Sellers Run for Cover From Major Pharma
The June 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest decreased.
7:38am ET
Health and Healthcare
How Major Pharma Is Faring After the Brexit
The broad markets are recovering in the wake of the Brexit and it really appears to be one big head fake. We are also realizing that the Brexit was a great opportunity…
8:11am ET
Health and Healthcare
Short Sellers Increase Bets Against Major Pharmaceutical Stocks
The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials.…
8:05am ET
Health and Healthcare
Major Pharma Has Short Sellers on the Run
The May 31 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
1:40pm ET
Health and Healthcare
How Credit Suisse Views Major Pharma After ASCO
The ASCO annual meeting is absolutely making waves in the pharmaceutical industry. As a result, analysts are giving their two cents on companies making presentations at the conference.
10:50am ET
Health and Healthcare
Merrill Lynch Picks ASCO Winners
Merrill Lynch is one of the major firms that will be in attendance at the American Society of Clinical Oncology (ASCO) annual meeting, and it has issued a report on what it…
10:15am ET
Health and Healthcare
Key Movers to Look for Ahead of ASCO
The American Society of Clinical Oncology (ASCO) is gearing up for its annual meeting. At this meeting, cancer drug developers will share the results from their most recent drug trials.
10:05am ET
Health and Healthcare
4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends
Despite the ongoing political candidate chirping, all of these quality big pharmaceutical stocks have been around, and they will continue to stay around.